2f3k: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2f3k.png|left|200px]] | [[Image:2f3k.png|left|200px]] | ||
{{STRUCTURE_2f3k| PDB=2f3k | SCENE= }} | {{STRUCTURE_2f3k| PDB=2f3k | SCENE= }} | ||
===Substrate envelope and drug resistance: crystal structure of r01 in complex with wild-type hiv-1 protease=== | ===Substrate envelope and drug resistance: crystal structure of r01 in complex with wild-type hiv-1 protease=== | ||
{{ABSTRACT_PUBMED_16569872}} | {{ABSTRACT_PUBMED_16569872}} | ||
==About this Structure== | ==About this Structure== | ||
[[2f3k]] is a 2 chain structure of [[Virus protease]] with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2F3K OCA]. | |||
==See Also== | |||
*[[Virus protease|Virus protease]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:016569872</ref><references group="xtra"/> | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
| Line 34: | Line 25: | ||
[[Category: Drug resistance]] | [[Category: Drug resistance]] | ||
[[Category: Hiv protease]] | [[Category: Hiv protease]] | ||
[[Category: Hydrolase]] | |||
[[Category: Ro1]] | [[Category: Ro1]] | ||
[[Category: Substrate envelope]] | [[Category: Substrate envelope]] | ||
Revision as of 14:07, 25 July 2012
Substrate envelope and drug resistance: crystal structure of r01 in complex with wild-type hiv-1 proteaseSubstrate envelope and drug resistance: crystal structure of r01 in complex with wild-type hiv-1 protease
Template:ABSTRACT PUBMED 16569872
About this StructureAbout this Structure
2f3k is a 2 chain structure of Virus protease with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Prabu-Jeyabalan M, King NM, Nalivaika EA, Heilek-Snyder G, Cammack N, Schiffer CA. Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease. Antimicrob Agents Chemother. 2006 Apr;50(4):1518-21. PMID:16569872 doi:50/4/1518